UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): JUNE 3, 2010
FIBROCELL SCIENCE, INC.
(Exact name of registrant as specified in its charter)
DELAWARE | 001-31564 | 87-0458888 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
405 EAGLEVIEW BLVD., EXTON, PA |
19341 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (484) 713-6000
ISOLAGEN, INC. |
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Shares voted FOR / WITHHELD / BROKER NON-VOTE |
||
Mr. Declan Daly:
|
12,615,670 / 736,123 / 2,753,537 | |
Shares voted FOR / WITHHELD / BROKER NON-VOTE |
||
Mr. Marc Mazur:
|
13,351,793 / 0 / 2,753,537 |
Shares voted FOR / AGAINST / ABSTAIN / BROKER NON-VOTE: |
||
16,103,330 / 2,000 / 0 / 0 |
Shares voted FOR / AGAINST / ABSTAIN / BROKER NON-VOTE: |
||
12,615,670 / 736,123 / 0 / 2,753,537 |
FIBROCELL SCIENCE, INC. |
||||
Date: June 3, 2010 | By: | /s/ Declan Daly | ||
Declan Daly | ||||
Chief Financial Officer & Chief Operating Officer |
||||
2